TXK and pancreatic neoplasm: In this study we have developed a novel oncolytic adenovirus that incorporate the optimized Tat8-TK gene controlled by the adenoviral major late promoter in an ICOVIR-5 backbone and show that the potency of the selective virus, ICOVIR5-TK-L, can be significantly improved when combined with GCV in pancreatic tumors.